Correlation Between Kilitch Drugs and Saksoft

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Saksoft at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Saksoft into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and Saksoft Limited, you can compare the effects of market volatilities on Kilitch Drugs and Saksoft and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Saksoft. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Saksoft.

Diversification Opportunities for Kilitch Drugs and Saksoft

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Kilitch and Saksoft is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Saksoft Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Saksoft Limited and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Saksoft. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Saksoft Limited has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Saksoft go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Saksoft

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 0.93 times more return on investment than Saksoft. However, Kilitch Drugs Limited is 1.07 times less risky than Saksoft. It trades about 0.07 of its potential returns per unit of risk. Saksoft Limited is currently generating about 0.06 per unit of risk. If you would invest  15,210  in Kilitch Drugs Limited on October 11, 2024 and sell it today you would earn a total of  19,300  from holding Kilitch Drugs Limited or generate 126.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.98%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  Saksoft Limited

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kilitch Drugs Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Saksoft Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Saksoft Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Kilitch Drugs and Saksoft Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and Saksoft

The main advantage of trading using opposite Kilitch Drugs and Saksoft positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Saksoft can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Saksoft will offset losses from the drop in Saksoft's long position.
The idea behind Kilitch Drugs Limited and Saksoft Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account